Product Pipeline

Pipeline

 
Our Pipeline Targets Large Cancer Indications
Read More >
Dedicated to Improving the Treatment of Cancer
Read More >

Pipeline

 
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
 
Disc
Pre
P1
P2
P3
ONT-380 - HER2+ Breast Cancer
 
 
 
 
 
ONT-380 + C + T versus
Placebo + C + T
 
 
 
 
 
+ Capecitabine (C) /
+ Trastuzumab (T) / or
+ C & T
 
 
 
 
 
ONT380 + T-DM1
 
 
 
 
 
Research Programs
 
 
 
 
 
Cell Cycle Checkpoint
 
 
 
 
 
Nucleic Acid Delivery
 
 
 
 
 
Immune Checkpoint
 
 
 
 
 
Licensed from Array BioPharma
Licensed from Sentinel Oncology
Research Collaboration with Adimab LLC
Our Pipeline Targets Large Cancer Indications
Read More >
Dedicated to Improving the Treatment of Cancer
Read More >